SPECIFICITY OF CALCIUM CHANNEL AUTOANTIBODIES IN LAMBERT-EATON MYASTHENIC SYNDROME

The Lancet

Volumn 334, Issue 8664, 1989, Pages 640-643

  Sher, E ^a   Canal, N ^b   Piccolo, G ^d   Gotti, C ^a   Scoppetta, C ^c   Evoli, A ^e   Clementi, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

CLINICAL ARTICLE; EATON LAMBERT SYNDROME; HUMAN; PRIORITY JOURNAL;

AUTOANTIBODIES; BINDING SITES; CALCIUM CHANNELS; CELLS, CULTURED; DIAGNOSIS, DIFFERENTIAL; HUMAN; MYASTHENIA GRAVIS; NERVOUS SYSTEM DISEASES; PRECIPITIN TESTS; RADIOIMMUNOASSAY; SUPPORT, NON-U.S. GOV'T; SYNDROME;

EID: 0024445344     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(89)90893-3     Document Type: Article

References (30)

1. The Lambert-Eaton myasthenic syndrome. A review of 50 cases
2. Myasthenic syndrome occasionally associated with bronchial neoplasm: neurophysiologic studies
3. On the release of transmitter at normal myasthenia gravis and myasthenic syndrome affected human endplates
4. Autonomic disfunction and Eaton-Lambert syndrome
5. Autoimmunity in the Lambert-Eaton myasthenic syndrome
6. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome
7. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma
8. Antibodies to motor nerve terminal: an electrophysiological study of a human myasthenic syndrome transferred to mouse
9. Passively transferred Lambert-Eaton syndrome in mice receiving purified IgG
10. Selected IgG rapidly induces Lambert-Eaton myasthenic syndrome in mice: complement independence and EMG abnormalities
11. Passive transfer of Lambert-Eaton mysathenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones
12. Lambert-Eaton myasthenic syndrome: 1. Early morphological effects of IgG on the presynaptic membrane active zones
13. Paucity and disorganization of presynaptic membrane active m the Lambert-Eaton myasthenic syndrome
14. 2+ flux in a human small carcinoma line
15. Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with or without Lambert-Eaton myasthenic syndrome by autoantibodies, ω-conotoxin and adenosine
16. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels
17. Calcium channel antagonists: omega-conotoxin GVIA defines a new high affinity site
18. Omega Conus geographus toxin: a peptide that blocks calcium channels
19. Neuronal calcium channel inhibitors
20. 2+ channels
21. Transmitter release from presynaptic terminals of electric organ: inhibition by the calcium channel antagonist omega Conus toxin
22. Inhibition of central neurotransmitter release by omega-conotoxin, a peptide modulator of the N-type voltage-sensitive calcium channel
23. ω-Conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle
24. Characterization of the omega-conotoxin target. Evidence for tissue-specific heterogeneity in calcium channel types
25. Omega-conotoxin binding and effects on calcium channel function in human neuroblastoma and rat pheochromocytoma cell lines
26. New antigen for antibody detection in myasthenia gravis
27. Pharmacological characterization of cholinergic receptors in a human neuroblastoma cell line
28. Antibody induced internalization of acetylcholine nicotinic receptor. kinetics mechanism and selectivity
29. Multiple calcium channels and neuronal function
30. Antibody-induced down regulation of membrane receptors in human diseases